Study details
Enrolling now
Excision of Lymph Node Trial (EXCILYNT)
Craig L Slingluff, Jr
NCT IDNCT05839912ClinicalTrials.gov data as of Apr 2026
Target enrollment
66
Study length
about 5 years
Ages
18+
Locations
7 sites in GA, MD, MI +4
What this study is about
Researchers are testing whether removing cancerous lymph nodes after treatment can prevent cancer from returning. The trial also aims to understand the side effects of this surgery and its impact on quality of life.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Undergo Excision of clinically detected lymph node metastasis after neoadjuvant systemic therapy
- 2.Undergo Excision of clinically detected lymph node metastasis before any systemic therapy
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Procedures
surgery
Body systems
Oncology